Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Arthritis Rheumatol. 2019 Nov 28;72(1):67–77. doi: 10.1002/art.41070

Figure 2:

Figure 2:

Physician determined change in peripheral neuropathy, mononeuropathy or cranial neuropathy (n=149) attributed to SLE and non-SLE using attribution model B. Top panel: Survival curves for resolution of all neuropathies (left) and individual neuropathies (right). Lower panel: Likert scale scores for physician assessment of outcome over the duration of followup are shifted to the right indicated improvement and this is most pronounced for cranial neuropathies (right).